Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors-Reference-Cited by-同舟云学术

Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors

Published:2017-02-17 Issue:4 Volume:3 Page:302-309
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Garzan Atefeh¹,Willby Melisa J.²,Ngo Huy X.¹,Gajadeera Chathurada S.¹,Green Keith D.¹,Holbrook Selina Y. L.¹,Hou Caixia¹,Posey James E.²,Tsodikov Oleg V.¹,Garneau-Tsodikova Sylvie¹^ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky, 789 South Limestone Street, Lexington, Kentucky 40536-0596, United States

2. Laboratory Branch, Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30329, United States

Funder

University of Kentucky

National Institute of Allergy and Infectious Diseases

Firland Foundation

College of Pharmacy, University of Kentucky

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.6b00193

Reference25 articles.